Market openNon-fractional
ATRION/ATRI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About ATRION
Atrion Corp develops and manufactures products for medical applications. Its fluid-delivery products contribute the largest proportion of revenue and include valves that can hold and release controlled amounts of fluids or gases and are often used in anesthesia and oncology applications. Atrion's cardiovascular products include the MPS2 Myocardial Protection System, which delivers fluids and medications, mixes drugs, and controls temperature and pressure during open-heart surgery. The cardiovascular business also sells cardiac-surgery vacuum relief valves, inflation devices, and other products used in heart surgery. The firm's ophthalmic products include medical devices that disinfect contact lenses. Atrion generates the majority of revenue in the United States.
Ticker
ATRI
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Allen, United States
Employees
712
Website
www.atrioncorp.com
ATRION Metrics
BasicAdvanced
$800M
Market cap
42.75
P/E ratio
$10.63
EPS
0.62
Beta
$8.75
Dividend rate
1.93%
Dividend yield
Price and volume
Market cap
$800M
Beta
0.62
Dividend rate
$8.75
Financial strength
Current ratio
9.183
Quick ratio
2.858
Dividend payout ratio (TTM)
82.27%
Interest coverage (TTM)
158.06%
Management effectiveness
Return on assets (TTM)
5.66%
Return on equity (TTM)
7.79%
Valuation
Price to earnings (TTM)
42.75
Price to revenue (TTM)
4.529
Price to book
2.91
Price to tangible book (TTM)
3.05
Price to free cash flow (TTM)
86.731
Dividend yield (TTM)
1.93%
Growth
Revenue change (TTM)
0.17%
Earnings per share change (TTM)
-36.95%
3-year revenue growth
7.26%
3-year earnings per share growth
-14.26%
3-year dividend per share growth
8.77%
ATRION Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$47M
8.74%
Net income
$2.7M
-57.81%
Profit margin
5.70%
-61.25%
ATRION News
AllArticlesVideos
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Atrion Corporation - ATRI
PRNewsWire·2 days ago
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Atrion Corporation
PRNewsWire·1 month ago
Shareholder Alert: Ademi LLP investigates whether Atrion Corporation has obtained a Fair Price for its Public Shareholders in its transaction with Nordson
PRNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market openNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for ATRION stock?
ATRION (ATRI) has a market cap of $800M as of July 05, 2024.
What is the P/E ratio for ATRION stock?
The price to earnings (P/E) ratio for ATRION (ATRI) stock is 42.75 as of July 05, 2024.
Does ATRION stock pay dividends?
Yes, the ATRION (ATRI) stock pays dividends to shareholders. As of July 05, 2024, the dividend rate is $8.75 and the yield is 1.93%. ATRION has a payout ratio of 82.27% on a trailing twelve-month basis.
When is the next ATRION dividend payment date?
The next ATRION (ATRI) dividend payment date is unconfirmed.
What is the beta indicator for ATRION?
ATRION (ATRI) has a beta rating of 0.62. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell ATRION stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.